| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 7.67M | — |
| Operating expense | — | — |
| Net income | -131.00M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, RXRX returned -29.1% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -14.4% |
| 1 year | -29.1% |
| 5 years | -86.1% |
| All-time high | $36.50 (Jun 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in RXRX would be worth today ›No. Recursion Pharmaceuticals, Inc. has not paid a dividend in the past 12 months.
Recursion Pharmaceuticals, Inc. stock trades on NASDAQ under the ticker symbol RXRX.
Recursion Pharmaceuticals, Inc. is part of the Healthcare sector.
Recursion Pharmaceuticals, Inc. has a market cap of 1.88B USD, based on the latest quote.
Recursion Pharmaceuticals, Inc. is expected to report earnings around Nov 4, 2026. That date is an estimate and has not been confirmed by the company.
